Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-25-006125
Filing Date
2025-10-15
Accepted
2025-10-15 16:30:44
Documents
1
Period of Report
2025-10-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4201
  Complete submission text file 0000919574-25-006125.txt   6197
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 700 CANAL STREET 2ND FLOOR STAMFORD CT 06902
Business Address 700 CANAL STREET 2ND FLOOR STAMFORD CT 06902 2035163690
Parkman Healthcare Partners LLC (Reporting) CIK: 0001777015 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39594 | Film No.: 251395177

Mailing Address 700 CANAL STREET STAMFORD CT 06902
Business Address
Martinez Gregory (Reporting) CIK: 0002091748 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39594 | Film No.: 251395176